Panel to debate paying for Pap vaccine

A life-saving vaccine that guards women against the Human Papilloma virus (HPV) may be given to grade-school girls.

By
December 4, 2007 01:20
school children teacher 298.88

children in school 224.8. (photo credit: Ariel Jerozolimski [file])

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

A life-saving vaccine that guards women against the Human Papilloma virus (HPV) will be given to grade-school girls, if the Finance Committee votes to include it in the 2008 health budget next week. On Monday, representatives from various women's organizations visited the Knesset to highlight the importance of the vaccine, Gardisil. HPV is a sexually transmitted disease that has been shown to lead to cervical cancer in women. More than 270,000 women die from cervical cancer each year. Most HPV infections do not exhibit any symptoms and go away without any treatment over the course of a few years. However, HPV infection sometimes persists for many years, and in a percentage of cases it leads to cell abnormalities that can cause cancer. Women must receive three doses of the vaccine, at a total cost of $360, for it to effectively prevent the disease. The cost of adding the vaccine to the health basket will be NIS 60 million, said a Finance Committee official. "This is an important vaccine and we will deliberate and consult with professionals when considering its addition," said a committee spokesman.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

[illustrative photo]
September 24, 2011
Diabetes may significantly increase risk of dementia

By UNIVERSITY OF MICHIGAN HEALTH SYSTEM